78 research outputs found
Granulocyte-Macrophage Colony-Stimulating Factor: Linking the Adaptive and Innate Immune Systems in Autoimmune Demyelinating Disease
Multiple sclerosis (MS) is a debilitating disorder of the central nervous system (CNS) characterized by motor, sensory, and visual deficits. Published literature supports the contention that MS is an autoimmune disease mediated by auto-reactive CD4+ T-helper (Th) cells which infiltrate the CNS from circulation. Infiltrating Th cells are reactivated within the CNS in an antigen-specific manner, driving recruitment, differentiation, and activation of circulating myeloid cells, and ultimately resulting in demyelination and axonopathy. Much work has been devoted to elucidating the roles of each of the known Th cell subsets, and the inflammatory mediators they produce, in CNS autoimmune disease. One Th cell mediator, granulocyte-macrophage colony-stimulating factor (GM-CSF), has been proposed to be a critical inflammatory cytokine that connects CNS-infiltrating Th cells with the pathogenic programming of tissue-invading myeloid cells. The aim of my dissertation project was to determine the mechanism of action of GM-CSF in the initiation, progression, and maintenance of experimental autoimmune encephalomyelitis (EAE), widely used as an animal model of MS.
The Segal lab and others have previously shown that C57BL/6 mice deficient in GM-CSF are resistant to EAE. We found that lymph node cells from immunized GM-CSF deficient mice mount an impaired MOG35-55-specific proliferative and cytokine response. Insufficient Th priming could explain, in part, the resistance of those mice to EAE. To study the role of GM-CSF during the effector phase, we transferred encephalitogenic T cells from MOG35-55-primed wild-type (WT) mice into naïve GM-CSF receptor-deficient mice (Csf2r-/-). Although Csf2r-/- recipients developed EAE with similar incidence and initial disease trajectory as their WT counterparts, they underwent clinical remission. The total number of cells infiltrating the CNS at peak EAE were comparable between groups, but neutrophils, myeloid-derived dendritic cells (mDCs), and MOG35-55-specific T cells were reduced in Csf2r-/- recipients. This suggested that either a paucity of infiltrating neutrophils, mDCs, and/ or encephalitogenic T cells could be responsible for the remitting phenotype exhibited by Csf2r-/- recipients.
To investigate the basis of the differences in the CNS infiltration, we compared chemokine expression in the spinal cords of WT and Csf2r-/- recipients during EAE. The myeloid cell chemoattractants CXCL1, CXCL2, and CCL2 were consistently comparable between groups, and CCL6 was comparable at disease onset but diverged thereafter. CCL6 levels progressively rose in the CNS of WT mice but dropped dramatically in Csf2r-/- mice by peak disease. CCR1, the sole receptor for CCL6, is expressed by subsets of leukocytes and has been detected on inflammatory cells in MS lesions. Its role in EAE remains to be elucidated. CCR1 blockade beginning at the time of T cell transfer reduced CNS-infiltration by monocytes and classical DCs (cDCs) and prevented the development of EAE. Conversely, CCR1 blockade following EAE onset triggered clinical remission associated with a reduction in CNS-infiltrating neutrophils, closely resembling the phenotype of Csf2r-/- recipients.
Together, these studies provide insight into the pleiotropic, and extensive, roles GM-CSF plays in the development and maintenance of CNS autoimmunity. We propose the following model: encephalitogenic T cells are reactivated in the CNS by cDCs and secrete GM-CSF. GM-CSF promotes the production of CCL6 within the CNS and expression of CCR1 by peripheral myeloid cells. CCL6:CCR1 interactions promote the migration of monocytes and neutrophils across the blood-brain-barrier and into the CNS parenchyma where they directly damage the myelin sheath and axons.PHDImmunologyUniversity of Michigan, Horace H. Rackham School of Graduate Studieshttps://deepblue.lib.umich.edu/bitstream/2027.42/150031/1/dunckerp_1.pd
Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation
BACKGROUND: Ischemia occurs frequently in hypertrophic cardiomyopathy
(HCM) without evidence of epicardial stenosis. This study evaluates the
hypothesis that the occurrence of ischemia in HCM is related to remodeling
of the coronary microcirculation. METHODS AND RESULTS: End-diastolic
septal wall thickness was significantly increased in patients with HCM
(25.8+/-2.9 mm) in comparison with cardiac transplant recipients (control
subjects: 11.4+/-3.0 mm; P<0.05). Although the diameter of the left
anterior descending coronary artery was similar in both groups (3.0+/-0.8
versus 3.0+/-0.5 mm, P=NS), the coronary resistance reserve
(CRR=CRRbasal/CRRhyperemic), corrected for extravascular compression
(end-diastolic left ventricular pressure), was reduced to 1.5+/-0.6 in HCM
(P<.05; control, 2.6+/-0.8). Arteriolar lumen (AL) divided by wall area
was lower in HCM (21+/-5% versus 30+/-4%; P<.05), and capillary density
tended to decrease (from 1824+/-424 to 1445+/-513 per mm2, P=.11) in HCM.
CRR was linearly related to normalized AL according to the formula CRR=O.1
AL-0.45 (r=.57; P<.05). Further analysis revealed that CRR, AL, and
capillary density were all linearly related to the degree of hypertrophy.
CONCLUSIONS: Decrements in CRR were related to changes of the coronary
microcirculation. Both the decrease in CRR and these changes in the
coronary microcirculation were related to the degree of hypertrophy. All
these factors might contribute to the well-known occurrence of ischemia in
this patient group
Effects of Primary Angioplasty for Acute Myocardial Infarction on Early and Late Infarct Size and Left Ventricular Wall Characteristics
Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration
AbstractObjectivesIn the absence of effective clinical pharmacotherapy for prevention of reperfusion-mediated injury, this study re-evaluated the effects of intracoronary adenosine on infarct size and no-reflow in a porcine model of acute myocardial infarction using clinical bolus and experimental high-dose infusion regimens.BackgroundDespite the clear cardioprotective effects of adenosine, when administered prior to ischemia, studies on cardioprotection by adenosine when administered at reperfusion have yielded contradictory results in both pre-clinical and clinical settings.MethodsSwine (54 ± 1 kg) were subjected to a 45-min mid–left anterior descending artery occlusion followed by 2 h of reperfusion. In protocol A, an intracoronary bolus of 3 mg adenosine injected over 1 min (n = 5) or saline (n = 10) was administered at reperfusion. In protocol B, an intracoronary infusion of 50 μg/kg/min adenosine (n = 15) or saline (n = 21) was administered starting 5 min prior to reperfusion and continued throughout the 2-h reperfusion period.ResultsIn protocol A, area-at-risk, infarct size, and no-reflow were similar between groups. In protocol B, risk zones were similar, but administration of adenosine resulted in significant reductions in infarct size from 59 ± 3% of the area-at-risk in control swine to 46 ± 4% (p = 0.02), and no-reflow from 49 ± 6% of the infarct area to 26 ± 6% (p = 0.03).ConclusionsDuring reperfusion, intracoronary adenosine can limit infarct size and no-reflow in a porcine model of acute myocardial infarction. However, protection was only observed when adenosine was administered via prolonged high-dose infusion, and not via short-acting bolus injection. These findings warrant reconsideration of adenosine as an adjuvant therapy during early reperfusion
Neutrophils promote VLA-4–dependent B cell antigen presentation and accumulation within the meninges during neuroinflammation
Recovery of left ventricular function after primary angioplasty for acute myocardial infarction.
AIMS: To study recovery of segmental wall thickening (SWT), ejection fraction (EF), and end-systolic volume (ESV) after acute myocardial infarction (AMI) in patients who underwent primary stenting with drug-eluting stents. Additionally, to evaluate the predictive value of magnetic resonance imaging (MRI)-based myocardial perfusion and delayed enhancement (DE) imaging. METHODS AND RESULTS: Twenty-two patients underwent cine-MRI, first-pass perfusion, and DE imaging 5 days after successful placement of a drug-eluting stent in the infarct-related coronary artery. Regional myocardial perfusion and the transmural extent of DE were evaluated. A per patient perfusion score was calculated and consisted of a summation of all segmental scores. Myocardial infarct size was quantified by measuring the volume of DE. At 5 months after AMI, cine-MRI was performed and SWT, EF, and ESV were quantified. EF increased from 48+/-11 to 55+/-9% (P<0.01). SWT at 5 months was inversely related to baseline segmental DE scores (P<0.001) and segmental perfusion scores (P<0.001). EF and ESV at 5 months were related to acute infarct size (R(2)=0.65; P<0.001 and R(2)=0.78; P<0.001, respectively) and the calculated perfusion score (R(2)=0.23; P=0.02 and R(2)=0.14; P=0.09, respectively) at baseline. CONCLUSION: Marked recovery of left ventricular function was observed in patients receiving a drug-eluting stent for AMI. DE imaging appears to be a better prognosticator than perfusion imaging
Neoatherosclerosis development following bioresorbable vascular scaffold implantation in diabetic and non-diabetic swine
Background: DM remains a risk factor for poor outcome after stent-implantation, but little is known if and how DM affects the vascular response to BVS. Aim: The aim of our study was to examine coronary responses to bioresorbable vascular scaffolds (BVS) in swine with and without diabetes mellitus fed a ‘fast-food’ diet (FF-DM and FF-NDM, respectively) by sequential optical coherence tomography (OCT)-imaging and histology. Methods: Fifteen male swine were evaluated. Eight received streptozotocin-injection to induce DM. After 9 months (M), 32 single BVS were implanted in epicardial arteries with a stent to artery (S/A)-ratio of 1.1:1 under quantitative coronary angiography (QCA) and OCT guidance. Lumen, scaffold, neointimal coverage and composition were assessed by QCA, OCT and near-infrared spectroscopy (NIRS) pre- and/or post-procedure, at 3M and 6M. Additionally, polarization-sensitive (PS)-OCT was performed in 7 swine at 6M. After sacrifice at 3M and 6M, histology and polymer degradation analysis were performed. Results: Late lumen loss was high (~60%) within the first 3M after BVS-implantation (P0.20). Neointimal coverage was highly heterogeneous in all swine (DM vs. NDM P>0.05), with focal lipid accumulation, irregular collagen distribution and neointimal calcification. Likewise, polymer mass loss was low (~2% at 3M, ~5% at 6M;P>0.20) and not associated with DM or inflammation. Conclusion: Scaffold coverage showed signs of neo-atherosclerosis in all FF-DM and FF-NDM swine, scaffold polymer was preserved and the vascular response to BVS was not influenced by diabetes
iSense: a technology platform for cold atom based quantum technologies
A breakthrough in cold atom quantum technology is hindered by a bottleneck in the supporting technologies. We discuss a cold atom technology platform developed within the European iSense project, aiming at a gravimeter as demonstrator
An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE
Abstract
Background
Myelin oligodendrocyte glycoprotein (MOG)-reactive T-helper (Th)1 cells induce conventional experimental autoimmune encephalomyelitis (cEAE), characterized by ascending paralysis and monocyte-predominant spinal cord infiltrates, in C57BL/6 wildtype (WT) hosts. The same T cells induce an atypical form of EAE (aEAE), characterized by ataxia and neutrophil-predominant brainstem infiltrates, in syngeneic IFNγ receptor (IFNγR)-deficient hosts. Production of ELR+ CXC chemokines within the CNS is required for the development of aEAE, but not cEAE. The cellular source(s) and localization of ELR+ CXC chemokines in the CNS and the IFNγ-dependent pathways that regulate their production remain to be elucidated.
Methods
The spatial distribution of inflammatory lesions and CNS expression of the ELR+ CXC chemokines, CXCL1 and CXCL2, were determined via immunohistochemistry and/or in situ hybridization. Levels of CXCL1 and CXCL2, and their cognate receptor CXCR2, were measured in/on leukocyte subsets by flow cytometric and quantitative PCR (qPCR) analysis. Bone marrow neutrophils and macrophages were cultured with inflammatory stimuli in vitro prior to measurement of CXCL2 and CXCR2 by qPCR or flow cytometry.
Results
CNS-infiltrating neutrophils and monocytes, and resident microglia, are a prominent source of CXCL2 in the brainstem of IFNγRKO adoptive transfer recipients during aEAE. In WT transfer recipients, IFNγ directly suppresses CXCL2 transcription in microglia and myeloid cells, and CXCR2 transcription in CNS-infiltrating neutrophils. Consequently, infiltration of the brainstem parenchyma from the adjacent meninges is blocked during cEAE. CXCL2 directly stimulates its own expression in cultured neutrophils, which is enhanced by IL-1 and suppressed by IFNγ.
Conclusions
We provide evidence for an IFNγ-regulated CXCR2/CXCL2 autocrine/paracrine feedback loop in innate immune cells that determines the location of CNS infiltrates during Th1-mediated EAE. When IFNγ signaling is impaired, myeloid cell production of CXCL2 increases, which promotes brainstem inflammation and results in clinical ataxia. IFNγ, produced within the CNS of WT recipients, suppresses myeloid cell CXCR2 and CXCL2 production, thereby skewing the location of neuroinflammatory infiltrates to the spinal cord and the clinical phenotype to an ascending paralysis. These data reveal a novel mechanism by which IFNγ and CXCL2 interact to direct regional recruitment of leukocytes in the CNS, resulting in distinct clinical presentations.https://deepblue.lib.umich.edu/bitstream/2027.42/145159/1/12974_2018_Article_1237.pd
Respiratory Evolution Facilitated the Origin of Pterosaur Flight and Aerial Gigantism
Pterosaurs, enigmatic extinct Mesozoic reptiles, were the first vertebrates to achieve true flapping flight. Various lines of evidence provide strong support for highly efficient wing design, control, and flight capabilities. However, little is known of the pulmonary system that powered flight in pterosaurs. We investigated the structure and function of the pterosaurian breathing apparatus through a broad scale comparative study of respiratory structure and function in living and extinct archosaurs, using computer-assisted tomographic (CT) scanning of pterosaur and bird skeletal remains, cineradiographic (X-ray film) studies of the skeletal breathing pump in extant birds and alligators, and study of skeletal structure in historic fossil specimens. In this report we present various lines of skeletal evidence that indicate that pterosaurs had a highly effective flow-through respiratory system, capable of sustaining powered flight, predating the appearance of an analogous breathing system in birds by approximately seventy million years. Convergent evolution of gigantism in several Cretaceous pterosaur lineages was made possible through body density reduction by expansion of the pulmonary air sac system throughout the trunk and the distal limb girdle skeleton, highlighting the importance of respiratory adaptations in pterosaur evolution, and the dramatic effect of the release of physical constraints on morphological diversification and evolutionary radiation
- …